ASX - Delayed Quote
AUD
Neuren Pharmaceuticals Limited (NEU.AX)
21.02
+0.87
(+4.32%)
At close: 4:10:12 PM GMT+10
Loading chart for NEU.AX
- Previous Close
20.15 - Open
20.08 - Bid 20.10 x --
- Ask 21.02 x --
- Day's Range
19.93 - 21.02 - 52 Week Range
11.00 - 23.76 - Volume
699,549 - Avg. Volume
563,248 - Market Cap (intraday)
2.665B - Beta (5Y Monthly) 1.59
- PE Ratio (TTM)
87.58 - EPS (TTM)
0.24 - Earnings Date (est.) --
- Forward Dividend & Yield 0.30 (1.43%)
- Ex-Dividend Date Sep 15, 2026
- 1y Target Est
25.35
Recent News
View MorePerformance Overview
Trailing total returns as of 8/27/2026, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
NEU.AX
12.95%
S&P/ASX 200 [XJO] (^AXJO)
3.72%
1-Year Return
NEU.AX
10.63%
S&P/ASX 200 [XJO] (^AXJO)
0.87%
3-Year Return
NEU.AX
68.16%
S&P/ASX 200 [XJO] (^AXJO)
27.03%
5-Year Return
NEU.AX
859.82%
S&P/ASX 200 [XJO] (^AXJO)
20.70%
Analyst Insights
View MoreStatistics
View MoreValuation Measures
As of 8/26/2026
-
Market Cap
2.55B
-
Enterprise Value
2.27B
-
Trailing P/E
86.59
-
Forward P/E
69.44
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
40.78
-
Price/Book (mrq)
7.55
-
Enterprise Value/Revenue
34.94
-
Enterprise Value/EBITDA
102.54
Financial Highlights
Profitability and Income Statement
-
Profit Margin
29.14%
-
Return on Assets (ttm)
2.58%
-
Return on Equity (ttm)
6.17%
-
Revenue (ttm)
69.53M
-
Net Income Avi to Common (ttm)
20.26M
-
Diluted EPS (ttm)
0.24
Balance Sheet and Cash Flow
-
Total Cash (mrq)
286.54M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-13.55M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
